CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Planned sale Watanabe Todd sold 3,172 shares at $23.61 ($74,893)
- 4 Planned sale Director sold 7,144 shares at $22.99 ($164,220)
- 4 Planned sale Director sold 10,000 shares at $23.88 ($238,801)
- 4 Planned sale Director sold 39,272 shares at $25.39 ($997,195)
- 4 Planned sale Director sold 10,000 shares at $25.65 ($256,518)
- 4 Planned sale Edwards Larry Todd sold 3,687 shares at an average $25.18 ($92,846)
- 4 Planned sale Watanabe Todd sold 37,349 shares at an average $25.18 ($940,528)
- 4 Planned sale Matsuda Masaru sold 12,058 shares at an average $26.03 ($313,877)
- 4 Planned sale SVP Chief Financial Officer sold 2,853 shares at an average $25.18 ($71,844)
- 4 Planned sale Burnett Patrick sold 6,287 shares at an average $25.18 ($158,320)
- 4 Planned sale Matsuda Masaru sold 40,638 shares at an average $25.28 ($1,027,293)
- 4 Planned sale Burnett Patrick sold 13,469 shares at an average $25.72 ($346,455)
- 4 Planned sale Watanabe Todd sold 19,833 shares at $25.50 ($505,710)
- 4 Planned sale SVP Chief Financial Officer sold 1,320 shares at $25.50 ($33,658)
- 4 Planned sale Director sold 10,000 shares at $25.05 ($250,483)
- 4 Planned sale Edwards Larry Todd sold 2,052 shares at $25.50 ($52,323)
- 4 Planned sale Burnett Patrick sold 2,490 shares at $28.98 ($72,166)
- 4 Planned sale Director sold 10,000 shares at $28.96 ($289,606)
- 4 Planned sale Burnett Patrick sold 1,697 shares at an average $29.20 ($49,560)
- 4 Planned sale Burnett Patrick sold 11,500 shares at $28.94 ($332,851)
Page 3 of 23 · 452 filings